Logo image of NXI.PA

NEXITY (NXI.PA) Stock Fundamental Analysis

EPA:NXI - FR0010112524 - Common Stock

8.445 EUR
-0.19 (-2.14%)
Last: 9/1/2025, 1:19:58 PM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to NXI. NXI was compared to 70 industry peers in the Real Estate Management & Development industry. Both the profitability and financial health of NXI have multiple concerns. NXI does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

NXI had negative earnings in the past year.
NXI had a positive operating cash flow in the past year.
NXI had positive earnings in 4 of the past 5 years.
Each year in the past 5 years NXI had a positive operating cash flow.
NXI.PA Yearly Net Income VS EBIT VS OCF VS FCFNXI.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

1.2 Ratios

The Return On Assets of NXI (-2.58%) is worse than 62.86% of its industry peers.
The Return On Equity of NXI (-8.58%) is worse than 65.71% of its industry peers.
Industry RankSector Rank
ROA -2.58%
ROE -8.58%
ROIC N/A
ROA(3y)0.44%
ROA(5y)1.29%
ROE(3y)2.37%
ROE(5y)6.1%
ROIC(3y)N/A
ROIC(5y)N/A
NXI.PA Yearly ROA, ROE, ROICNXI.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40 -60

1.3 Margins

Looking at the Gross Margin, with a value of 23.71%, NXI is in line with its industry, outperforming 42.86% of the companies in the same industry.
In the last couple of years the Gross Margin of NXI has declined.
NXI does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 23.71%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-9.27%
GM growth 5Y-6.55%
NXI.PA Yearly Profit, Operating, Gross MarginsNXI.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

3

2. Health

2.1 Basic Checks

NXI does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for NXI has been increased compared to 1 year ago.
Compared to 5 years ago, NXI has more shares outstanding
NXI has a worse debt/assets ratio than last year.
NXI.PA Yearly Shares OutstandingNXI.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
NXI.PA Yearly Total Debt VS Total AssetsNXI.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.2 Solvency

Based on the Altman-Z score of 0.97, we must say that NXI is in the distress zone and has some risk of bankruptcy.
NXI has a Altman-Z score (0.97) which is in line with its industry peers.
The Debt to FCF ratio of NXI is 10.36, which is on the high side as it means it would take NXI, 10.36 years of fcf income to pay off all of its debts.
NXI's Debt to FCF ratio of 10.36 is fine compared to the rest of the industry. NXI outperforms 72.86% of its industry peers.
NXI has a Debt/Equity ratio of 0.87. This is a neutral value indicating NXI is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.87, NXI perfoms like the industry average, outperforming 45.71% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.87
Debt/FCF 10.36
Altman-Z 0.97
ROIC/WACCN/A
WACC2.86%
NXI.PA Yearly LT Debt VS Equity VS FCFNXI.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.3 Liquidity

NXI has a Current Ratio of 1.35. This is a normal value and indicates that NXI is financially healthy and should not expect problems in meeting its short term obligations.
NXI has a Current ratio (1.35) which is comparable to the rest of the industry.
NXI has a Quick Ratio of 1.35. This is a bad value and indicates that NXI is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.73, NXI is in line with its industry, outperforming 44.29% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.35
Quick Ratio 0.73
NXI.PA Yearly Current Assets VS Current LiabilitesNXI.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

1

3. Growth

3.1 Past

NXI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -419.40%.
Looking at the last year, NXI shows a very negative growth in Revenue. The Revenue has decreased by -16.43% in the last year.
NXI shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -4.52% yearly.
EPS 1Y (TTM)-419.4%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-214.9%
Revenue 1Y (TTM)-16.43%
Revenue growth 3Y-9.31%
Revenue growth 5Y-4.52%
Sales Q2Q%-17.67%

3.2 Future

Based on estimates for the next years, NXI will show a very strong growth in Earnings Per Share. The EPS will grow by 35.45% on average per year.
Based on estimates for the next years, NXI will show a decrease in Revenue. The Revenue will decrease by -4.66% on average per year.
EPS Next Y28.91%
EPS Next 2Y40.59%
EPS Next 3Y35.45%
EPS Next 5YN/A
Revenue Next Year-19.05%
Revenue Next 2Y-8.46%
Revenue Next 3Y-4.66%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
NXI.PA Yearly Revenue VS EstimatesNXI.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B 4B
NXI.PA Yearly EPS VS EstimatesNXI.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 1 -1 2 3

3

4. Valuation

4.1 Price/Earnings Ratio

NXI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year NXI is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NXI.PA Price Earnings VS Forward Price EarningsNXI.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -100 -200

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of NXI indicates a somewhat cheap valuation: NXI is cheaper than 65.71% of the companies listed in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of NXI indicates a rather cheap valuation: NXI is cheaper than 94.29% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 2.44
EV/EBITDA 19.54
NXI.PA Per share dataNXI.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40 50

4.3 Compensation for Growth

A more expensive valuation may be justified as NXI's earnings are expected to grow with 35.45% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y40.59%
EPS Next 3Y35.45%

6

5. Dividend

5.1 Amount

NXI has a Yearly Dividend Yield of 17.45%, which is a nice return.
NXI's Dividend Yield is rather good when compared to the industry average which is at 8.26. NXI pays more dividend than 94.29% of the companies in the same industry.
NXI's Dividend Yield is rather good when compared to the S&P500 average which is at 2.32.
Industry RankSector Rank
Dividend Yield 17.45%

5.2 History

The dividend of NXI decreases each year by -0.01%.
Dividend Growth(5Y)-0.01%
Div Incr Years0
Div Non Decr Years0
NXI.PA Yearly Dividends per shareNXI.PA Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 0.5 1 1.5 2 2.5

5.3 Sustainability

DP0%
EPS Next 2Y40.59%
EPS Next 3Y35.45%
NXI.PA Yearly Income VS Free CF VS DividendNXI.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

NEXITY

EPA:NXI (9/1/2025, 1:19:58 PM)

8.445

-0.19 (-2.14%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)07-24 2025-07-24
Earnings (Next)10-23 2025-10-23
Inst Owners35.04%
Inst Owner ChangeN/A
Ins Owners0.13%
Ins Owner ChangeN/A
Market Cap474.02M
Analysts78
Price Target11.9 (40.91%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 17.45%
Yearly Dividend2.51
Dividend Growth(5Y)-0.01%
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)2.19%
PT rev (3m)2.19%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)14.8%
EPS NY rev (3m)14.8%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.63%
Revenue NY rev (3m)1.13%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.16
P/FCF 2.44
P/OCF 1.96
P/B 0.27
P/tB 0.91
EV/EBITDA 19.54
EPS(TTM)-2.72
EYN/A
EPS(NY)-0.03
Fwd EYN/A
FCF(TTM)3.46
FCFY40.97%
OCF(TTM)4.3
OCFY50.94%
SpS54.4
BVpS31.48
TBVpS9.23
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.58%
ROE -8.58%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 23.71%
FCFM 6.36%
ROA(3y)0.44%
ROA(5y)1.29%
ROE(3y)2.37%
ROE(5y)6.1%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-9.27%
GM growth 5Y-6.55%
F-Score4
Asset Turnover0.52
Health
Industry RankSector Rank
Debt/Equity 0.87
Debt/FCF 10.36
Debt/EBITDA 15.31
Cap/Depr 26.75%
Cap/Sales 1.55%
Interest Coverage N/A
Cash Conversion 240.19%
Profit Quality N/A
Current Ratio 1.35
Quick Ratio 0.73
Altman-Z 0.97
F-Score4
WACC2.86%
ROIC/WACCN/A
Cap/Depr(3y)30.71%
Cap/Depr(5y)31.16%
Cap/Sales(3y)1.5%
Cap/Sales(5y)1.48%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-419.4%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-214.9%
EPS Next Y28.91%
EPS Next 2Y40.59%
EPS Next 3Y35.45%
EPS Next 5YN/A
Revenue 1Y (TTM)-16.43%
Revenue growth 3Y-9.31%
Revenue growth 5Y-4.52%
Sales Q2Q%-17.67%
Revenue Next Year-19.05%
Revenue Next 2Y-8.46%
Revenue Next 3Y-4.66%
Revenue Next 5YN/A
EBIT growth 1Y-137.66%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year143.99%
EBIT Next 3Y55.17%
EBIT Next 5YN/A
FCF growth 1Y-25.42%
FCF growth 3Y62.63%
FCF growth 5Y-7.99%
OCF growth 1Y-26.5%
OCF growth 3Y33.4%
OCF growth 5Y-7.85%